» Articles » PMID: 23817579

Host Genetic Background Impacts Modulation of the TLR4 Pathway by RON in Tissue-associated Macrophages

Overview
Publisher Wiley
Date 2013 Jul 3
PMID 23817579
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptors (TLRs) enable metazoans to mount effective innate immune responses to microbial and viral pathogens, as well as to endogenous host-derived ligands. It is understood that genetic background of the host can influence TLR responsiveness, altering susceptibility to pathogen infection, autoimmunity and cancer. Macrophage stimulatory protein (MSP), which activates the receptor tyrosine kinase recepteur d'origine nantais (RON), promotes key macrophage functions such as motility and phagocytic activity. MSP also acts via RON to modulate signaling by TLR4, which recognizes a range of pathogen or endogenous host-derived molecules. Here, we show that RON exerts divergent control over TLR4 activity in macrophages from different mouse genetic backgrounds. RON potently modulated the TLR4 response in macrophages from M2-prone FVB mice, as compared with M1-skewed C57Bl6 mice. Moreover, global expression analysis revealed that RON suppresses the TLR4-dependent type-I interferon gene signature only in FVB macrophages. This leads to attenuated production of the potent inflammatory mediator, tumor necrosis factor-α. Eliminating RON kinase activity markedly decreased carcinogen-mediated tumorigenesis in M2/Th2-biased FVB mice. We propose that host genetic background influences RON function, thereby contributing to the variability in TLR4 responsiveness in rodents and, potentially, in humans. These findings provide novel insight into the complex interplay between genetic context and immune function.

Citing Articles

Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma.

Zhao Y, Yang T, Ouyang Y, Rao W, Liu K, Zheng J Front Immunol. 2024; 15:1339213.

PMID: 38348038 PMC: 10859425. DOI: 10.3389/fimmu.2024.1339213.


A network map of macrophage-stimulating protein (MSP) signaling.

Sanjeev D, Dagamajalu S, Shaji V, George M, Subbannayya Y, Keshava Prasad T J Cell Commun Signal. 2023; 17(3):1113-1120.

PMID: 37142846 PMC: 10409925. DOI: 10.1007/s12079-023-00755-w.


An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.

Hunt B, Fox L, Davis J, Jones A, Lu Z, Waltz S Genes (Basel). 2023; 14(2).

PMID: 36833444 PMC: 9956929. DOI: 10.3390/genes14020517.


MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.

Huang L, Fang X, Shi D, Yao S, Wu W, Fang Q Front Immunol. 2020; 11:569082.

PMID: 33117355 PMC: 7577085. DOI: 10.3389/fimmu.2020.569082.


TLR4, but Neither Dectin-1 nor Dectin-2, Participates in the Mollusk Hemocyanin-Induced Proinflammatory Effects in Antigen-Presenting Cells From Mammals.

Jimenez J, Salazar M, Arancibia S, Villar J, Salazar F, Brown G Front Immunol. 2019; 10:1136.

PMID: 31214162 PMC: 6554540. DOI: 10.3389/fimmu.2019.01136.


References
1.
Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View

2.
Lemmon M, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2010; 141(7):1117-34. PMC: 2914105. DOI: 10.1016/j.cell.2010.06.011. View

3.
Dunn G, Koebel C, Schreiber R . Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006; 6(11):836-48. DOI: 10.1038/nri1961. View

4.
Kline J, Cowden J, Hunninghake G, Schutte B, Watt J, POWERS L . Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med. 1999; 160(1):297-303. DOI: 10.1164/ajrccm.160.1.9808144. View

5.
Bhattacharya D, Yusuf N . Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Int J Breast Cancer. 2012; 2012:716564. PMC: 3262598. DOI: 10.1155/2012/716564. View